These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 1315900)

  • 1. Antipyretic effect of central arginine8-vasopressin treatment: V1 receptors specifically involved?
    Kovacs GL; Baars AM; De Wied D
    Life Sci; 1992; 50(21):1625-30. PubMed ID: 1315900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proconvulsive effect of vasopressin; mediation by a putative V2 receptor subtype in the central nervous system.
    Croiset G; De Wied D
    Brain Res; 1997 Jun; 759(1):18-23. PubMed ID: 9219858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Barrel rotation induced by central arginine8-vasopressin treatment: involvement of neurohypophyseal peptide receptors.
    Diamant M; Baars AM; Kovács GL; De Wied D
    Pharmacol Biochem Behav; 1994 Jan; 47(1):27-32. PubMed ID: 8115425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interactive effects of neurohypophyseal neuropeptides with receptor antagonists on passive avoidance behavior: mediation by a cerebral neurohypophyseal hormone receptor?
    de Wied D; Elands J; Kovács G
    Proc Natl Acad Sci U S A; 1991 Feb; 88(4):1494-8. PubMed ID: 1847526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vasopressin-induced antipyresis in the medial amygdaloid nucleus of conscious rats.
    Federico P; Veale WL; Pittman QJ
    Am J Physiol; 1992 May; 262(5 Pt 2):R901-8. PubMed ID: 1534208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An exploration of the effects of L- and D-tetrahydroisoquinoline-3-carboxylic acid substitutions at positions 2, 3 and 7 in cyclic and linear antagonists of vasopressin and oxytocin and at position 3 in arginine vasopressin.
    Manning M; Cheng LL; Stoev S; Bankowski K; Przybyiski J; Klis WA; Sawyer WH; Wo NC; Chan WY
    J Pept Sci; 1995; 1(1):66-79. PubMed ID: 9222985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indomethacin-induced antipyresis in the rat: role of vasopressin receptors.
    Fyda DM; Cooper KE; Veale WL
    Brain Res; 1989 Aug; 494(2):307-14. PubMed ID: 2528390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New antagonists of the vasopressin receptor mediated contraction in rat tail artery.
    Petrusewicz J; Damasiewicz B; Kaliszan R; Juzwa W; Lammek B; Derdowska I
    Pharmacol Res; 1992; 25(2):167-72. PubMed ID: 1386154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arginine vasopressin (AVP) replacement of helper cell requirement in IFN-gamma production. Evidence for a novel AVP receptor on mouse lymphocytes.
    Torres BA; Johnson HM
    J Immunol; 1988 Apr; 140(7):2179-83. PubMed ID: 2965181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Excitation of neurones in the rat paraventricular nucleus in vitro by vasopressin and oxytocin.
    Inenaga K; Yamashita H
    J Physiol; 1986 Jan; 370():165-80. PubMed ID: 3007746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological characterization of V1a vasopressin receptors in the rat cortical collecting duct.
    Ammar A; Roseau S; Butlen D
    Am J Physiol; 1992 Apr; 262(4 Pt 2):F546-53. PubMed ID: 1533099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central effects of vasopressin and 1-desamino-8-D-arginine vasopressin (DDAVP) on interleukin-1 fever in the rat.
    Naylor AM; Gubitz GJ; Dinarello CA; Veale WL
    Brain Res; 1987 Jan; 401(1):173-7. PubMed ID: 2949799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of vasopressin and other neuropeptides on rostral medullary sympathoexcitatory neurons 'in vitro'.
    Sun MK; Guyenet PG
    Brain Res; 1989 Jul; 492(1-2):261-70. PubMed ID: 2752300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The positive feedback action of vasopressin on its own release from rat septal tissue in vitro is receptor-mediated.
    Landgraf R; Ramirez AD; Ramirez VD
    Brain Res; 1991 Apr; 545(1-2):137-41. PubMed ID: 1830507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and characterization of a vasopressin isoreceptor in porcine seminal vesicles.
    Maggi M; Kassis S; Malozowski S; Guardabasso V; Rodbard D
    Proc Natl Acad Sci U S A; 1986 Dec; 83(23):8824-8. PubMed ID: 2947237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Central vasopressin V1-blockade prevents salicylate but not acetaminophen antipyresis.
    Wilkinson MF; Kasting NW
    J Appl Physiol (1985); 1990 May; 68(5):1793-8. PubMed ID: 2361881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vasopressin reduces release from vasopressin-neurons and oxytocin-neurons by acting on V2-like receptors.
    Cheng SW; North WG
    Brain Res; 1989 Feb; 479(1):35-9. PubMed ID: 2522339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. V1- and V2-receptor contributions to ovine fetal renal and cardiovascular responses to vasopressin.
    Ervin MG; Ross MG; Leake RD; Fisher DA
    Am J Physiol; 1992 Apr; 262(4 Pt 2):R636-43. PubMed ID: 1566929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological characterization of vasotocin stimulation of phosphoinositide turnover in frog adrenal gland.
    Larcher A; Delarue C; Homo-Delarche F; Kikuyama S; Kupryszewski G; Vaudry H
    Endocrinology; 1992 Jan; 130(1):475-83. PubMed ID: 1309345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. V2-like vasopressin receptor mobilizes intracellular Ca2+ in rat medullary collecting tubules.
    Champigneulle A; Siga E; Vassent G; Imbert-Teboul M
    Am J Physiol; 1993 Jul; 265(1 Pt 2):F35-45. PubMed ID: 8342613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.